Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Epirubicin Hydrochloride

Epirubicin Hydrochloride

Inquiry
  Post Date: Apr 12,2017
  Expiry Date: Apr 12,2018
  Detailed Description: Cas No. :125317-39-7 Anti-cancer API



  CAS Registry Number:

125317-39-7
  Synonyms: ;Vinorelbine bitartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt;Navelbine tartrate;Nvb;Navelbine;Vinorelbin;Bitartrate;Vinorelbine ditartaric acid;Vinorelbine ditartrate salt;Butanedioate(1:2);C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy;5'-noranhydrovinoblastine tartrate;3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine;[R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt];Pacilitaxel;Vinorelbineditartrate salt hydrate;Vinorelbine tartrate usp standard;Vinorelbine tartrate;Vinorelbine bitratrate;Vinorelbine tartarate;methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2);methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate;(3Ar,3A1R,4R,5S,5Ar,10Br)-Methyl 4-Acetoxy-3A-Ethyl-9-((2S,6S,8S)-4-Ethyl-8-(Methoxycarbonyl)-1,3,6,7,8,9-Hexahydro-2,6-Methanoazecino[4,3-B]Indol-8-Yl)-5-Hydroxy-8-Methoxy-6-Methyl-3A,3A1,4,5,5A,6,11;
  Molecular Formula: C45H54N4O8
  Molecular Weight: 778.9323
  Molecular Structure: 125317-39-7 Vinorelbine Ditartrate
  Hazard Symbols:  Xi:Irritant;
  Risk Codes: R43:;
  Safety Description: S26:;
S36:;

  Company: Beijing JingSource Pharmaceutical Technology Co., Ltd.     [ China ]        
  Contact: Spencer Lin
  Tel: +86+10-52865516
  Fax: +86+10-67602253
  Email: spencer@jingsource.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.